tradmap

ILMN Illumina, Inc.

$161.79 +1.68%

Healthcare · Laboratory Analytical Instruments

Illumina, Inc. (ILMN) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $24.5 billion. Shares last traded at $161.79, 8.7% below their 52-week high. Over the past year the stock is up 81.2%. ILMN trades at a price-to-earnings ratio of 28.80, above the Laboratory Analytical Instruments median of 28.17. Net profit margin is 19.6%, above the peer median of -1.5%. Revenue declined 0.7% year over year.

Market Cap
$24.5B
Shares Out
151.3M
EPS (TTM)
$7.29
P/E Ratio
22.19
P/S Ratio
5.64
P/B Ratio
9.15
Dividend / Share
Dividend Yield
52-Week High
$177.12
52-Week Low
$88.00
Volume
60,066
Avg Vol (3m)
94,457.524

Performance

1W
-2.61%
1M
+14.23%
3M
+27.86%
6M
+23.01%
YTD
+20.40%
1Y
+81.18%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
56.91
SMA (50)
$144.52
SMA (200)
$126.70
Price vs SMA50
+11.95%
Price vs SMA200
+27.70%
ATR (14)
$6.22

Financials

Revenue
$4.3B
Net Income
$850M
Gross Margin
66.1%
Operating Margin
18.6%
Net Margin
19.6%
Return on Equity
31.8%
Return on Assets
13.0%
Current Ratio
1.75
Debt / Equity
0.25
Revenue Growth (YoY)
-0.7%

Latest reported annual period ending 2025-12-28 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.87 2026-05-04
FY 2025 $5.45 2026-02-12
Q3 2025 $3.29 2025-10-31
Q2 2025 $2.31 2025-08-01
Q1 2026 $0.82 2026-05-04
FY 2025 $-7.69 2026-02-12

Full earnings history →

Laboratory Analytical Instruments peers

ILMN vs 14 industry peers (Laboratory Analytical Instruments), by market cap.

P/E vs peers
28.80 / 28.17 med
+2% premium
P/S vs peers
5.64 / 2.95 med
+91% premium
Net margin vs peers
19.6% / -1.5% med
above median
1–14 of 14
AAgilent Technologies$35.9B27.555.1718.8%+2.23%
WATWaters Corporation$34.9B54.3211.0320.3%-0.44%
ILMNIllumina, Inc.$24.5B28.805.6419.6%+1.68%
MTDMettler Toledo$23.1B26.595.7421.6%+1.22%
RVTYRevvity$11.1B46.223.908.4%+2.23%
BRKRBruker Corp$8.7B-1049.062.53-0.2%+4.51%
BIOBio-Rad Laboratories, Inc.$7.6B10.022.9529.4%-0.80%
AVTRAvantor, Inc.$6.5B-12.321.00-8.1%+1.16%
TXG10x Genomics, Inc.$4.5B-102.516.94-6.8%+8.24%
ALMRAlamar Biosciences, Inc.$1.5B+8.56%
EYPTEyepoint, Inc.$1.1B-4.91+3.35%
CTKBCytek Biosciences, Inc.$488M-7.342.42-33.0%-4.91%
PACBPacific Biosciences Of California, Inc.$432M-0.79+3.35%
LABSTANDARD BIOTOOLS INC.$324M-4.323.79-87.8%+2.65%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.